DOCS vs EPAM
Doximity, Inc. and Epam Systems, Inc., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | DOCS | EPAM |
|---|---|---|
| Revenue | $644.9M | $5.5B |
| Net income | $196.1M | $377.7M |
| Gross margin | 89.1% | 28.8% |
| Net margin | 30.4% | 6.9% |
| Return on equity | 19.3% | 10.3% |
| Diluted EPS | $0.98 | $6.72 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $326.5M | $612.7M |
| Equity | $950.8M | $3.7B |
| Net debt / equity | · | −0.35× |
| Current ratio | 6.09× | 2.59× |
| Revenue CAGR 5y | 25.5% | 15.5% |
| Profit CAGR 5y | 31.3% | 2.9% |
EPAM bills 8.5× the revenue of DOCS, and DOCS keeps more of each dollar of revenue as profit (30.4% against 6.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
7 years side by side
| Fiscal year | DOCS | EPAM |
|---|---|---|
| FY2025 | $644.9M | $5.5B |
| FY2024 | $570.4M | $4.7B |
| FY2023 | $475.4M | $4.7B |
| FY2022 | $419.1M | $4.8B |
| FY2021 | $343.5M | $3.8B |
| FY2020 | $206.9M | $2.7B |
| FY2019 | $116.4M | $2.3B |
Bottom line
| Fiscal year | DOCS | EPAM |
|---|---|---|
| FY2025 | $196.1M | $377.7M |
| FY2024 | $223.2M | $454.5M |
| FY2023 | $147.6M | $417.1M |
| FY2022 | $112.8M | $419.4M |
| FY2021 | $154.8M | $481.7M |
| FY2020 | $50.2M | $327.2M |
| FY2019 | $29.7M | $261.1M |
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$4,812,193,000 | EPAM |
| FY2024 | −$4,157,541,000 | EPAM |
| FY2023 | −$4,215,118,000 | EPAM |
| FY2022 | −$4,405,646,000 | EPAM |
| FY2021 | −$3,414,596,000 | EPAM |
| FY2020 | −$2,452,581,000 | EPAM |
| FY2019 | −$2,177,410,000 | EPAM |
EPAM has reported the higher revenue in every one of these 7 fiscal years. The gap has widened since the earliest year compared.
7 of 16 comparable fiscal years — a year missing data on either side is not counted.
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +23.5 pp | DOCS |
| FY2024 | +29.5 pp | DOCS |
| FY2023 | +22.2 pp | DOCS |
| FY2022 | +18.2 pp | DOCS |
| FY2021 | +32.2 pp | DOCS |
| FY2020 | +12.0 pp | DOCS |
| FY2019 | +14.2 pp | DOCS |
DOCS has kept the higher net margin in every one of these 7 fiscal years.
7 of 16 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
DOCS's net margin has been more volatile than EPAM's over the 7 comparable fiscal years — 7.1 percentage points of standard deviation against 2.0.
7 of 16 comparable fiscal years — a year missing data on either side is not counted.
Year by year
DOCS led in net margin in every one of the 7 comparable fiscal years — a structural lead, not a recent swing.
7 of 16 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
DOCS's return on equity has been more volatile than EPAM's over the 7 comparable fiscal years — 902.5 percentage points of standard deviation against 3.6.
7 of 16 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between DOCS and EPAM over these 7 fiscal years — DOCS led in 6 and EPAM in 1.
7 of 16 comparable fiscal years — a year missing data on either side is not counted.